1. Home
  2. SNDA vs INBX Comparison

SNDA vs INBX Comparison

Compare SNDA & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$32.55

Market Cap

501.8M

Sector

Health Care

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$80.41

Market Cap

430.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDA
INBX
Founded
1990
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
501.8M
430.2M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
SNDA
INBX
Price
$32.55
$80.41
Analyst Decision
Hold
Hold
Analyst Count
1
2
Target Price
$28.00
N/A
AVG Volume (30 Days)
65.0K
319.4K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$327,007,000.00
$1,400,000.00
Revenue This Year
$25.63
$563.00
Revenue Next Year
$6.18
$230.77
P/E Ratio
N/A
N/A
Revenue Growth
29.15
N/A
52 Week Low
$19.34
$10.81
52 Week High
$33.50
$87.84

Technical Indicators

Market Signals
Indicator
SNDA
INBX
Relative Strength Index (RSI) 66.51 60.24
Support Level $32.19 $78.26
Resistance Level $33.48 $86.23
Average True Range (ATR) 0.80 6.40
MACD -0.08 -1.31
Stochastic Oscillator 51.30 51.78

Price Performance

Historical Comparison
SNDA
INBX

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: